The Asia-Pacific botanical and plant derivative drug market generated the highest revenue of $15954 million in the year 2017 as compared to the other regional markets. The market is slated to flourish further between the forecast years of 2018-2026, by growing at the highest CAGR of 9.01%. The widespread infectious, as well as respiratory diseases like asthma, bronchitis, lung cancer, cholera, and tuberculosis, are responsible for increasing the demand of the market in this region.
ASIA PACIFIC BOTANICAL & PLANT DERIVATIVE DRUG MARKET FORECAST 2018-2026
Asia Pacific Botanical and Plant Derivative Drug Market by Types (Terpenes, Steroids, Glycosides, Phenols & Other Types) by Therapeutic Applications (Oncology, Dermatology, Cns Disorders, Hormone Diseases, & Other) by Products & Geography
The Asia-Pacific botanical and plant derivative drug market generated the highest revenue of $15954 million in the year 2017 as compared to the other regional markets. The market is slated to flourish further between the forecast years of 2018-2026, by growing at the highest CAGR of 9.01%. The widespread infectious, as well as respiratory diseases like asthma, bronchitis, lung cancer, cholera, and tuberculosis, are responsible for increasing the demand of the market in this region.
To learn more about this report, request a free sample copy
India, Japan, China, South-Korea, Australia, and the rest of Asia-Pacific are the markets considered for this region. The Indian market is predicted to rise with the highest CAGR over the forecast period. The practice of ancient Ayurveda in the region along with the emerging herbal drug industry is mainly responsible for propelling the market forward. According to a 2015 report by the National Institute of Health, approximately 960 plant species have been discovered by the Indian herbal industry. The export of these plant species or the botanical drug derived from them contributes significantly to the market economy. The Asia-Pacific market is segmented on the basis of types, therapeutic applications, and products. Also, the considerable investments made by multinational companies such as GE Healthcare and GlaxoSmithKline in the Asia-Pacific market has significantly contributed to the market growth.
Some of the noted botanical and plant derivative drug manufacturing companies in the region are Abbott Pharmaceuticals, GlaxoSmithKline, Piramal Phytocare Ltd, Glenmark Pharmaceuticals Ltd, Pfizer international, Ranbaxy Laboratories Ltd (Acquired By Sun Pharmaceuticals Ltd), Novartis International Ag, Lupin Ltd, Bayer Healthcare Llc, and others.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- INDIAN BOTANICAL AND PLANT DERIVATIVE DRUGS MARKET TO OFFER GREAT OPPORTUNITIES
- GLYCOSIDES IS A QUICKLY RISING MARKET IN TERMS OF TYPES
- ONCOLOGY HOLDS THE LARGEST MARKET SHARE IN TERMS OF THERAPEUTIC APPLICATION
- DEMAND FOR HERBAL/TRADITIONAL TOPICAL ANALGESICS PRODUCT IS GROWING RAPIDLY
- MARKET DYNAMICS
- DRIVERS
- GROWING APPLICATIONS IN DISEASES
- GROWING FDA APPROVALS
- TECHNOLOGICAL DEVELOPMENT IN THE MANUFACTURING PROCESS
- RISING DEMAND FOR TRADITIONAL MEDICINES
- GROWING FOCUS TOWARDS NATURAL SOURCE MEDICINES
- RESTRAINTS
- STRINGENT REGULATIONS REGARDING THE USE AND APPROVAL OF BOTANICAL DRUGS
- LIMITED ADOPTION OF BOTANICAL AND PLANT DERIVATIVE DRUGS
- OPPORTUNITIES
- RISING FDA APPROVALS FOR BOTANICAL DRUGS
- ESCALATING USAGE OF BOTANICAL DRUGS
- INCREASING INVESTMENT IN ASIA PACIFIC
- CHALLENGES
- PRESENCE OF SUBSTITUTES FOR BOTANICAL & PLANT DERIVATIVE DRUG
- TOXICITY RELATED ISSUES AND SAFETY CONCERNS
- DRIVERS
- MARKET SEGMENTATION
- MARKET BY TYPES 2018-2026
- TERPENES
- STEROIDS
- GLYCOSIDES
- PHENOLS
- OTHER TYPES
- MARKET BY THERAPEUTIC APPLICATIONS 2018-2026
- ONCOLOGY
- DERMATOLOGY
- CNS DISORDERS
- HORMONE DISEASES
- OTHER THERAPEUTIC APPLICATIONS
- MARKET BY PRODUCTS 2018-2026
- HERBAL/TRADITIONAL TOPICAL ANALGESICS
- HERBAL/TRADITIONAL COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
- HERBAL/TRADITIONAL DIGESTIVE REMEDIES
- HERBAL/TRADITIONAL DERMATOLOGICAL
- HERBAL/TRADITIONAL PEDIATRIC DIETARY SUPPLEMENTS
- HERBAL/TRADITIONAL DIETARY SUPPLEMENTS
- HERBAL/TRADITIONAL TONICS
- MARKET BY TYPES 2018-2026
- KEY ANALYTICS
- MANUFACTURING PROCESS
- VALUE CHAIN ANALYSIS
- LEGAL, POLICY AND REGULATORY FRAMEWORK
- PORTER’S FIVE FORCES ANALYSIS
- THREAT OF NEW ENTRANTS
- THREATS OF SUBSTITUTE PRODUCT
- BARGAINING POWER OF BUYER
- BARGAINING POWER OF SUPPLIER
- INTENSITY OF COMPETITIVE RIVALRY
- KEY BUYING CRITERIA
- GEOGRAPHIC ANALYSIS
- ASIA-PACIFIC
- CHINA
- INDIA
- JAPAN
- AUSTRALIA
- SOUTH KOREA
- REST OF ASIA-PACIFIC
- ASIA-PACIFIC
- COMPETITIVE LANDSCAPE
- KEY STRATEGIES
- MERGER & ACQUISITION
- PARTNERSHIP & COLLABORATION
- EXPANSION & INVESTMENT
- MARKET SHARE ANALYSIS
- KEY COMPANIES ANALYSIS
- KEY STRATEGIES
- COMPANY PROFILE
- ABBOTT LABORATORIES
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- SCOT ANALYSIS
- ANALYTICON DISCOVERY GMBH
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- BAYER HEALTHCARE LLC
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- BOEHRINGER INGELHEIM
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- BIONOVA
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- BRISTOL-MYERS SQUIBB
- OVERVIEW
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- CURA PHARM
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- WILLMAR SCHWABE GMBH & CO. KG
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- ELI LILLY AND COMPANY
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- GLAXOSMITHKLINE
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- SCOT ANALYSIS
- GLENMARK PHARMACEUTICALS LTD.
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- INDENA VIALE ORTLES
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- LUPIN LTD
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- MEDIGENE
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- SCOT ANALYSIS
- NOVARTIS INTERNATIONAL AG
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- SCOT ANALYSIS
- PFIZER
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- PIRAMAL PHYTOCARE LTD.
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- RANBAXY LABORATORIES LTD (ACQUIRED BY SUN PHARMACEUTICALS LTD)
- OVERVIEW
- PRODUCTION PORTFOLIO
- STRATEGIC INITIATIVE-
- SCOT ANALYSIS
- SANOFI
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- TASLY PHARMACEUTICALS INC.
- OVERVIEW
- PRODUCTION PORTFOLIO
- SCOT ANALYSIS
- ABBOTT LABORATORIES
TABLE LIST
TABLE 1Â Â Â Â Â Â ASIA PACIFIC BOTANICAL & PLANT DERIVATIVE DRUG MARKET, 2018-2026 ($ MILLION)
TABLE 2Â Â Â Â Â Â ASIA PACIFIC BOTANICAL & PLANT DERIVATIVE DRUG MARKET, BY TYPES 2018-2026 ($ MILLION)
TABLE 3Â Â Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN TERPENES, 2018-2026 ($ MILLION)
TABLE 4Â Â Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN STEROIDS 2018-2026 ($ MILLION)
TABLE 5Â Â Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN GLYCOSIDES, BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 6Â Â Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN PHENOLS, 2018-2026 ($ MILLION)
TABLE 7Â Â Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHER TYPES 2018-2026 ($ MILLION)
TABLE 8Â Â Â Â Â Â ASIA PACIFIC BOTANICAL & PLANT DERIVATIVE DRUG MARKET BY THERAPEUTIC APPLICATIONS 2018-2026 ($ MILLION)
TABLE 9Â Â Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN ONCOLOGY, 2018-2026 ($ MILLION)
TABLE 10Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN DERMATOLOGY, 2018-2026 ($ MILLION)
TABLE 11Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN CNS DISORDERS, 2018-2026 ($ MILLION)
TABLE 12Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HORMONE DISEASE, 2018-2026 ($ MILLION)
TABLE 13Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHERS THERAPEUTIC APPLICATIONS 2018-2026 ($ MILLION)
TABLE 14Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET, BY PRODUCT 2018-2026 ($ MILLION)
TABLE 15Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TOPICAL ANALGESICS, 2018-2026 ($ MILLION)
TABLE 16Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES, 2018-2026 ($ MILLION)
TABLE 17Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIGESTIVE REMEDIES, 2018-2026 ($ MILLION)
TABLE 18Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DERMATOLOGICALS, 2018-2026 ($ MILLION)
TABLE 19Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL PAEDIATRIC DIETARY SUPPLEMENTS, 2018-2026 ($ MILLION)
TABLE 20Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIETARY SUPPLEMENTS, 2018-2026 ($ MILLION)
TABLE 21Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TONICS, 2018-2026 ($ MILLION)
TABLE 22Â Â Â Â ASIA PACIFIC BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)
          Â
FIGURE LIST
FIGURE 1Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)
FIGURE 2Â Â Â Â INDIA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)
FIGURE 3Â Â Â Â ASIA PACIFIC BOTANICAL & PLANT DERIVATIVE DRUG MARKET IN GLYCOSIDES 2018-2026 ($ MILLION)
FIGURE 4Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN TERPENES 2018-2026 ($ MILLION)
FIGURE 5Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN STEROIDS 2018-2026 ($ MILLION)
FIGURE 6Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN GLYCOSIDES 2018-2026 ($ MILLION)
FIGURE 7Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN PHENOLS 2018-2026 ($ MILLION)
FIGURE 8Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHER TYPES 2018-2026 ($ MILLION)
FIGURE 9Â Â Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN ONCOLOGY 2018-2026 ($ MILLION)
FIGURE 10Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN DERMATOLOGY 2018-2026 ($ MILLION)
FIGURE 11Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN CNS DISORDERS 2018-2026 ($ MILLION)
FIGURE 12Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HORMONE DISEASE 2018-2026 ($ MILLION)
FIGURE 13Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHERS THERAPEUTIC APPLICATIONS 2018-2026 ($ MILLION)
FIGURE 14Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TOPICAL ANALGESICS 2018-2026 ($ MILLION)
FIGURE 15Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES 2018-2026 ($ MILLION)
FIGURE 16Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIGESTIVE REMEDIES 2018-2026 ($ MILLION)
FIGURE 17Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DERMATOLOGICALS 2018-2026 ($ MILLION)
FIGURE 18Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL PAEDIATRIC DIETARY SUPPLEMENTS 2018-2026 ($ MILLION)
FIGURE 19Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIETARY SUPPLEMENTS 2018-2026 ($ MILLION)
FIGURE 20Â Â ASIA PACIFIC BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TONICS 2018-2026 ($ MILLION)
FIGURE 21Â Â EVOLUTION OF BOTANICAL AND PLANT DERIVATIVE DRUGS
FIGURE 22Â Â CHINA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)
FIGURE 23Â Â INDIA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)
FIGURE 24Â Â JAPAN BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)
FIGURE 25Â Â AUSTRALIA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)
FIGURE 26Â Â SOUTH KOREA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)
FIGURE 27Â Â REST OF ASIA PACIFIC BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)
FIGURE 28Â Â BOTANICAL & PLANT DERIVATIVE DRUG MARKET SHARE 2017
- GEOGRAPHIC ANALYSIS
- ASIA-PACIFIC
- CHINA
- INDIA
- JAPAN
- AUSTRALIA
- SOUTH KOREA
- REST OF ASIA-PACIFIC
- ASIA-PACIFIC
- MARKET SEGMENTATION
- MARKET BY TYPES 2018-2026
- TERPENES
- STEROIDS
- GLYCOSIDES
- PHENOLS
- OTHER TYPES
- MARKET BY THERAPEUTIC APPLICATIONS 2018-2026
- ONCOLOGY
- DERMATOLOGY
- CNS DISORDERS
- HORMONE DISEASES
- OTHER THERAPEUTIC APPLICATIONS
- MARKET BY PRODUCTS 2018-2026
- HERBAL/TRADITIONAL TOPICAL ANALGESICS
- HERBAL/TRADITIONAL COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
- HERBAL/TRADITIONAL DIGESTIVE REMEDIES
- HERBAL/TRADITIONAL DERMATOLOGICAL
- HERBAL/TRADITIONAL PEDIATRIC DIETARY SUPPLEMENTS
- HERBAL/TRADITIONAL DIETARY SUPPLEMENTS
- HERBAL/TRADITIONAL TONICS
- MARKET BY TYPES 2018-2026
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
Choose License Type
RELATED REPORTS
-
ASIA-PACIFIC HYALURONIC ACID MARKET FORECAST 2025-2032
-
ASIA-PACIFIC COLLAGEN MARKET FORECAST 2025-2032
-
ASIA-PACIFIC ATV AND UTV MARKET FORECAST 2025-2032
-
ASIA-PACIFIC GAMING MARKET FORECAST 2025-2032
-
ASIA-PACIFIC ORTHOGNATHIC CRANIOMAXILLOFACIAL (CMF) DEVICES MARKET FORECAST 2025-2032
-
GLOBAL HALAL PHARMACEUTICALS MARKET FORECAST 2025-2032
-
ASIA-PACIFIC HALAL PHARMACEUTICALS MARKET FORECAST 2025-2032
-
EUROPE HALAL PHARMACEUTICALS MARKET FORECAST 2025-2032
-
NORTH AMERICA HALAL PHARMACEUTICALS MARKET FORECAST 2025-2032
-
LATIN AMERICA HALAL PHARMACEUTICALS MARKET FORECAST 2025-2032